Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 6
Author(s): Franco Patrone
Affiliation:
Export Options
About this article
Cite this article as:
Patrone Franco , Meet Our Editorial Board Member, Current Cancer Drug Targets 2018; 18 (6) . https://dx.doi.org/10.2174/156800961806180611103149
DOI https://dx.doi.org/10.2174/156800961806180611103149 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
23
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melanoma: Prognostic Factors and Factors Predictive of Response to Therapy
Current Medicinal Chemistry Enhanced Expression of miR-199b-5p Promotes Proliferation of Pancreatic β-Cells by Down-Regulation of MLK3
MicroRNA The Development of Hyaluronan as a Drug Transporter and Excipient for Chemotherapeutic Drugs
Current Pharmaceutical Biotechnology Is Type 2 Diabetes Mellitus a Predisposal Cause for Developing Hepatocellular Carcinoma?
Current Diabetes Reviews Editorial: Azoles in Anticancer Research: Rational Approaches, Design Strategies, Recent Insights and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenetic Variation and Metformin Response
Current Drug Metabolism Prognostic Factors after R0 Resection of Colorectal Cancer Liver Metastases: A Systematic Review and Pooled-Analysis
Reviews on Recent Clinical Trials Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Microwave-Assisted Synthesis, Antimicrobial and Cytotoxic Activities of Some 4-Thioxo-Thiazolidine-2-One Derivatives
Letters in Drug Design & Discovery Meet Our Regional Editor
Anti-Cancer Agents in Medicinal Chemistry Editorial
Current Cancer Therapy Reviews The Role of Epithelial-Mesenchymal Interactions in Tissue Repair, Fibrogenesis and Carcinogenesis
Current Signal Transduction Therapy Mechanisms of Trastuzumab Resistance in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Current Cancer Drug Targets Immunological and Translational Aspects of Glycolytic Metabolism in Various Human Tumor Entities
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Tetracyclic Triterpenoids in Herbal Medicines and their Activities in Diabetes and its Complications
Current Topics in Medicinal Chemistry Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia
Current Pharmacogenomics The AmpliChip: A Review of its Analytic and Clinical Validity and Clinical Utility
Current Drug Safety Folding Versus Charge: Understanding Selective Target Recognition by the Thrombin Aptamers
Current Pharmaceutical Design Cytotoxic Molecules from Natural Sources: Tapping the Brazilian Biodiversity
Anti-Cancer Agents in Medicinal Chemistry